Chennai | Our institute is doing studies to reduce the treatment duration of drug-sensitive Tuberculosis (TB) from 6 months to 4 months & drug-resistant TB to 6 months. Both the studies are being done for adults and adolescents: Dr Padmapriyadarsini C, Director, ICMR- NIRT (04.7) pic.twitter.com/UlBp4udTXG— ANI (@ANI) July 5, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


